Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks ...

Both companies offer different ED treatments and a similar business model, but what are the differences between BlueChew and Hims, and which one might be right for you? Founded in 2017 ...

Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock is still undervalued and why ...

Per management, HIMS’ model is rapidly gaining scale, thereby driving top-line growth, improving profitability and strong cash flow. On theearnings call management confirmed that the company ...

RKLX, the Defiance Daily Target 2X Long RKLB ETF, seeks daily investment results that correspond to twice (200%) the daily percentage change of Rocket Lab, a company at the forefront of satellite ...

With the FDA shutting down its key revenue stream, Hims faces a tough road ahead--can it justify its valuation?

the future model of health and wellness that centers around the consumer and the consumer alone," CEO Andrew Dudum said on the call Monday. Hims & Hers is focused on bringing disruption to ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.